The therapeutic armamentarium for heart failure with preserved ejection fraction (HFpEF) remains notably constrained. A factor contributing to this problem could be the scarcity of in vitro models for ...
hClinical Trial Service Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK iMedical Research Council Health Research Unit, Nuffield Department of Population Health, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback